NCT04992585

Brief Summary

The aim is to compare percutaneous transhepatic biliary drainage (PTBD) with primary metal stent implantation (one stage-procedure) with PTBD with secondary metal stent implantation in terms of adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2021

Completed
Last Updated

August 12, 2021

Status Verified

August 1, 2021

Enrollment Period

10 years

First QC Date

August 1, 2021

Last Update Submit

August 5, 2021

Conditions

Keywords

Bile Duct ObstructionSelf Expandable Metallic Stents

Outcome Measures

Primary Outcomes (1)

  • Adverse events

    All adverse events which have been documented in the medical record were analyzed and classified as mild, moderate, severe or fatal/death according to the AE severity grading system of the American Society of Gastrointestinal Endoscopy (ASGE)

    From the intervention until 30 days after

Study Arms (2)

PTBD with primary metal stent implantation

EXPERIMENTAL

PTBD with primary metal stent implantation is performed in the same session as a one step-procedure

Device: Percutaneous transhepatic implantation of self-expandable metal stent

PTBD with secondary metal stent implantation

ACTIVE COMPARATOR

PTBD with secondary metal stent implantation is performed as a two step-procedure with metal stent implantation 3 to 7 days after previous percutaneous transhepatic biliary drainage and insertion of a plastic catheter

Device: Percutaneous transhepatic implantation of self-expandable metal stent

Interventions

A self-expandable metal stent is inserted into the extrahepatic bile duct which is obstructed by malignant disease

PTBD with primary metal stent implantationPTBD with secondary metal stent implantation

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PTBD with metal stent implantation into the extrahepatic bile duct
  • malignant and non-resectable extrahepatic bile duct obstruction

You may not qualify if:

  • benign extrahepatic bile duct obstruction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tertiary referral hospital: Theresienkrankenhaus und St. Hedwig Hospital, Academic

Mannheim, 68165, Germany

Location

Related Publications (3)

  • Sharaiha RZ, Khan MA, Kamal F, Tyberg A, Tombazzi CR, Ali B, Tombazzi C, Kahaleh M. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017 May;85(5):904-914. doi: 10.1016/j.gie.2016.12.023. Epub 2017 Jan 4.

    PMID: 28063840BACKGROUND
  • Venkatanarasimha N, Damodharan K, Gogna A, Leong S, Too CW, Patel A, Tay KH, Tan BS, Lo R, Irani F. Diagnosis and Management of Complications from Percutaneous Biliary Tract Interventions. Radiographics. 2017 Mar-Apr;37(2):665-680. doi: 10.1148/rg.2017160159.

    PMID: 28287940BACKGROUND
  • Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. No abstract available.

    PMID: 20189503BACKGROUND

MeSH Terms

Conditions

CholestasisCholestasis, Extrahepatic

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System Diseases

Study Officials

  • Daniel Schmitz, MD

    Theresienkrankenhaus Mannheim, University of Heidelberg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Retrospective comparison of two similar interventions with small modification
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2021

First Posted

August 5, 2021

Study Start

March 1, 2011

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

August 12, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations